Table 2.
Video consent approved (n = 3485 patients; 60 sites) |
Video consent not approved (n = 4419 patients; 80 sites) |
P- value | |
---|---|---|---|
Demographics | |||
Age | 68 (60, 75) | 67 (59, 74) | < 0.001 |
Age ≥ 75 years old | 959 (27.5%) | 1041 (23.6%) | < 0.001 |
Female gender | 1809 (51.9%) | 2348 (53.1%) | 0.26 |
Race | < 0.001 | ||
White | 2868 (82.3%) | 3793 (85.8%) | |
African American | 537 (15.4%) | 534 (12.1%) | |
Asian | 66 (1.9%) | 84 (1.9%) | |
American Indian/Alaskan | 7 (0.2%) | 4 (0.1%) | |
Insurance | < 0.001 | ||
Private | 2113 (60.6%) | 2458 (55.6%) | |
Government | 1277 (36.6%) | 1850 (41.9%) | |
Other | 3 (0.1%) | 0 (0.0%) | |
None | 71 (2.0%) | 108 (2.4%) | |
College graduate or higher | 1069 (30.7%) | 1573 (35.6%) | <0.001 |
Clinical Characteristics | |||
Atherosclerotic vascular disease | 1450 (41.6%) | 1977 (44.7%) | 0.005 |
Coronary artery disease | 1206 (34.6%) | 1624 (36.8%) | 0.05 |
Peripheral vascular disease | 284 (8.2%) | 419 (13.4%) | 0.04 |
Cerebrovascular disease | 437 (12.5%) | 593 (13.4%) | 0.25 |
History of MI | 342 (9.8%) | 666 (15.1%) | < 0.001 |
Diabetes | 1216 (34.9%) | 1847 (41.8%) | < 0.001 |
Hypertension | 2679 (76.9%) | 3446 (78.0%) | 0.25 |
Current/recent smoker | 463 (13.3%) | 597 (13.5%) | 0.77 |
Chronic kidney disease | 360 (10.3%) | 393 (8.9%) | 0.03 |
Currently taking statin | 2399 (68.8%) | 3253 (73.6%) | < 0.001 |
Core lab LDL-C level | 99 (77, 126) | 94 (73, 120) | <0.001 |
Continuous variables expressed as median (25th, 75th percentile); categorical variables expressed as number (%).